Reviewed by Michael Gill, B. Sc.
8 Anaplastic Thyroid Cancer Clinical Trials Near Me
Top Hospitals for Anaplastic Thyroid Cancer Clinical Trials
Image of M D Anderson Cancer Center in Texas.
M D Anderson Cancer Center
Houston
4Active Trials
7All Time Trials for Anaplastic Thyroid Cancer
2010First Anaplastic Thyroid Cancer Trial
Image of Northwestern University in Illinois.
Northwestern University
Chicago
2Active Trials
2All Time Trials for Anaplastic Thyroid Cancer
2014First Anaplastic Thyroid Cancer Trial
Top Cities for Anaplastic Thyroid Cancer Clinical Trials
Image of Anchorage in Alaska.
Anchorage
9Active Trials
Anchorage Associates in Radiation MedicineTop Active Site
Image of Honolulu in Hawaii.
Honolulu
9Active Trials
Hawaii Cancer Care Inc-POB IITop Active Site
Anaplastic Thyroid Cancer Clinical Trials by Phase of Trial
Phase < 1 Anaplastic Thyroid Cancer Clinical Trials
1Active Anaplastic Thyroid Cancer Clinical Trials
1Number of Unique Treatments
7Number of Active Locations
Anaplastic Thyroid Cancer Clinical Trials by Age Group
18+ Anaplastic Thyroid Cancer Clinical Trials
7Active Anaplastic Thyroid Cancer Clinical Trials
Top Treatments for Anaplastic Thyroid Cancer Clinical Trials
Treatment Name
Active Anaplastic Thyroid Cancer Clinical Trials
All Time Trials for Anaplastic Thyroid Cancer
First Recorded Anaplastic Thyroid Cancer Trial
Vudalimab
1
1
2022
Quality-of-Life Assessment
1
3
2018
Dabrafenib
1
4
2020
Pembrolizumab
1
6
2016
Autologous Tumor Infiltrating Lymphocytes LN-145
1
1
2018
Recently Completed Studies with FDA Approved Treatments for Anaplastic Thyroid Cancer
Treatment
Year
Sponsor
durvalumab
2017
Memorial Sloan Kettering Cancer Center

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 1st, 2021

Last Reviewed: November 7th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. Lancet. 2016 Dec 3;388(10061):2783-2795. doi: 10.1016/S0140-6736(16)30172-6. Epub 2016 May 27. Review. https://pubmed.ncbi.nlm.nih.gov/27240885